NICE technology appraisal guidance
Issued: September 2008
TA158

Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza

This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta158

6 Recommendations for further research

6.1 Research is required into methods of delivering zanamivir to the under-5 age group and to establish the effectiveness of such treatment.

6.2 Research is required to develop options for prophylaxis of influenza in infants (under 12 months of age).